Nasonex and Tykerb drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasonex (mometasone furoate monohydrate) and Tykerb (lapatinib ditosylate). Common drug interactions include sinusitis among females and gastrointestinal haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Nasonex and Tykerb. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

What is Tykerb?

Tykerb has active ingredients of lapatinib ditosylate. It is often used in breast cancer. eHealthMe is studying from 12,231 Tykerb users. Check the latest studies of Tykerb.

On Jul, 27, 2026

20 people who take Nasonex and Tykerb together, and have interactions are studied.

What are the common drug interactions of Nasonex and Tykerb, by gender? *:

female:

Sinusitis (inflammation of sinus)
Nausea (feeling of having an urge to vomit)
Dyspnoea (difficult or laboured respiration)
Malignant neoplasm progression (cancer tumour came back)
Metastases to bone (cancer spreads to bone)
Metastases to liver (cancer spreads to liver)
Somnolence (a state of near-sleep, a strong desire for sleep)
Dizziness
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety

male:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Abdominal pain
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Ascites (accumulation of fluid in the abdominal cavity)
Back pain
Blood glucose decreased
Bone pain
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiomegaly (increased size of heart than normal)

What are the common drug interactions of Nasonex and Tykerb, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Diarrhoea
Oral pain

50-59:

Anxiety
Cardiomegaly (increased size of heart than normal)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Dermal cyst
Disability
Dyspnoea (difficult or laboured respiration)
Escherichia sepsis (bacterial infection by escherichia coli)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

60+:

Abdominal pain
Diarrhoea
Metastases to bone (cancer spreads to bone)
Metastases to liver (cancer spreads to liver)
Muscular weakness (muscle weakness)
Nausea (feeling of having an urge to vomit)
Rash
Somnolence (a state of near-sleep, a strong desire for sleep)
Abscess (pus)
Acanthosis (thickening of the skin)

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 10 people, 50.00%
Type 2 Diabetes: 1 person, 5.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 5.00%
Muscle Spasms (muscle contraction): 1 person, 5.00%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.00%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.00%
High Blood Pressure: 1 person, 5.00%
Depression: 1 person, 5.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nasonex and Tykerb?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously